Skip to content

Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery

A Randomized Controlled Trial of Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03028623
Enrollment
44
Registered
2017-01-23
Start date
2017-05-01
Completion date
2018-03-05
Last updated
2018-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Method of Tubal Ligation at the Time of Cesarean Section

Brief summary

The objective of this study is to evaluate the feasibility and safety of salpingectomy versus standard tubal ligation in women undergoing surgical sterilization at the time of a planned cesarean delivery. Salpingectomy is currently being investigated as a potential strategy for ovarian cancer prevention. While this procedure is currently performed during hysterectomies, its feasibility at the time of cesarean delivery is not well established. This randomized, prospective clinical trial will compare the two sterilization methods to demonstrate that salpingectomy compared with standard tubal ligation at the time of cesarean delivery will not result in increased operative time, blood loss or other complications. This study is necessary to promote salpingectomy as a standard sterilization method during cesarean deliveries.

Interventions

PROCEDURESalpingectomy

Bilateral salpingectomy will be performed instead of standard tubal ligation as sterilization during cesarean section.

Standard tubal ligation by either Parkland or Pomeroy technique will be performed at cesarean section

Sponsors

University of Virginia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects must have planned cesarean delivery and desire sterilization * Subjects must be able to read and provide written informed consent * Subjects must be English or Spanish speaking

Exclusion criteria

* Subjects with known hereditary cancer syndromes * Subjects with a history of prior tubal surgery * Subjects with a placenta accreta * Subjects undergoing trial of labor after cesarean delivery

Design outcomes

Primary

MeasureTime frameDescription
Time of tubal ligationat time of procedurePrimary outcome will be the time it takes to complete the sterilization procedure

Secondary

MeasureTime frameDescription
Total procedure timeat time of procedureThe total time it takes to complete the cesarean plus sterilization procedure
Estimated blood lossat time of procedureEstimated blood loss for the entire procedure
Rate of aborted proceduresat time of procedureInability to complete bilateral salpingectomy in the experimental arm

Other

MeasureTime frameDescription
Length of staywithin 1008 hoursLength of stay in hours
Readmission ratewithin 6 weeksRate of readmission within 6 weeks
Reoperation ratewithin 6 weeksRate of reoperation within 6 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026